Beijing Strong Biotechnologies,Inc. (SZSE: 300406)
Health Care · Biotechnology · CN
CN¥11.70
-3.15% today · -21.9% 1Y
Beijing Strong Biotechnologies,Inc. (SZSE: 300406) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.02B and employs 998 people.
Over the last twelve months the share price has lost 21.9%, trading between 10.52 and 16.05.
Tweenvest scores Beijing Strong Biotechnologies,Inc. across four factors: quality 76/100, value 49/100, growth 16/100, dividend 56/100. Its strongest factor is quality.
300406 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.02B
- Revenue (TTM)
- $201.07M
- P/E
- 30.86
- EPS
- 0.38
- Dividend yield
- 5.98%
- Beta (5Y)
- 0.28
- 52-week high
- CN¥16.05
- 52-week low
- CN¥10.52
- Avg volume (3M)
- —
- Shares outstanding
- 584.78M
- Employees
- 998
- Next earnings
- —
About Beijing Strong Biotechnologies,Inc.
Beijing Strong Biotechnologies, Inc. operates as a supplier of in-vitro diagnostic (IVD) solutions, encompassing both products and associated services, for markets within the People's Republic of China and globally. The firm's comprehensive product line includes offerings for clinical biochemistry, such as diagnostic reagents and sophisticated automated analyzers. Additionally, it provides coagulation-related items, including necessary reagents and automated analysis instrumentation. Furthermore, its serology division delivers blood type testing cards and advanced automated systems for blood grouping. This enterprise was established in 2001 and has its corporate headquarters situated in Beijing, China.
- ISIN
- CNE100001Y26
- Founded
- 2001
- Listed since
- Oct 30, 2014
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.